FRAMINGHAM (09/24/2003) - At BIO 2003, U.K.-based biotech Pro2Kem Ltd. officially launched its first product, the AggreKem protein aggregation monitor for biopolymer analysis, in the U.S. market. The compact system employs light-scattering techniques to rapidly screen for protein aggregation studies using low volumes of sample.
AggreKem's application-specific software allows for accurate determination of aggregation levels in drug formulations and directly targets disciplines such as protein crystallography.
Pro2Kem says it designed the system to provide a hardware platform on which a range of networked analysis systems for studying protein-protein interactions, determining biopolymer molecular weight distributions, and so on, could be based. AggreKem is upgradable and customizable.
Product Name: AggreKem
For more information: +44 1382-523189; or www.pro2kem.com